Scale of the Epidemic Remains Daunting (Image Credits: Unsplash)
The global HIV epidemic continued to challenge health systems worldwide at the end of 2024, with nearly 41 million people affected despite decades of intervention efforts.[1]
Scale of the Epidemic Remains Daunting
UNAIDS reported that 40.8 million people lived with HIV in 2024, including 39.4 million adults aged 15 and older and 1.4 million children under 15.[1] New infections reached 1.3 million that year, a figure largely unchanged from the prior period and far exceeding the 2025 target of under 370,000.[1] AIDS-related deaths totaled 630,000, down 54 percent from 2010 levels but still claiming a life every minute.[1]
Sub-Saharan Africa accounted for 65 percent of all cases, with eastern and southern Africa alone hosting 21.1 million people living with HIV.[2] These numbers highlight how the virus disproportionately burdens certain regions while global prevalence among adults aged 15-49 hovered at 0.7 percent.
Vulnerable Groups Face Heightened Risks
Women and girls comprised 53 percent of adults living with HIV, with 4,000 adolescent girls and young women aged 15-24 becoming infected weekly – 3,300 of them in sub-Saharan Africa.[1] Key populations experienced median prevalence rates up to 8.5 percent among transgender people and 7.6 percent among gay men and other men who have sex with men between 2020 and 2024.[1]
- Children aged 0-14: 120,000 new infections, 86 percent in sub-Saharan Africa.
- Sex workers: 2.7 percent prevalence.
- People who inject drugs: 7.1 percent prevalence.
- Prison populations: 1.4 percent prevalence.
Progress against mother-to-child transmission reduced child infections by 62 percent since 2010, yet 250 children still died daily from AIDS-related causes in 2024.[1]
Treatment Access Improves but Lags Behind
Some 31.6 million people – 77 percent of those living with HIV – received antiretroviral therapy in 2024, a sharp rise from 7.7 million in 2010.[1] Viral suppression reached 73 percent overall, with 94 percent of those on treatment achieving it.[1] Adults fared better at 78 percent on treatment compared to 55 percent for children.
The 95-95-95 targets for 2025 – 95 percent diagnosed, on treatment, and virally suppressed – stood unmet at 87 percent, 77 percent, and 73 percent respectively.[1] Women outperformed men in access, with 83 percent of pregnant women on therapy.
Funding Shortfalls Spark Alarm
A 2025 funding crisis disrupted services after major donors withdrew support, risking 6 million additional infections and 4 million deaths by 2029 if unresolved.[3] Available resources hit $18.7 billion, 17 percent below needs, with international aid funding 80 percent of prevention in low- and middle-income countries.[1]
UNAIDS Executive Director Winnie Byanyima noted, “The AIDS response may be in crisis, but we have the power to transform.”[3] Twenty-five countries boosted domestic spending into 2026 amid these pressures.
Revitalized Responses and New Tools Emerge
The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) saved 26 million lives and supported 20 million on treatment by late 2022, though recent uncertainties loomed.[2] New long-acting preventives like lenacapavir promised twice-yearly injections to curb infections.[3]
UNAIDS unveiled a Global AIDS Strategy for 2026-2031 targeting 3.3 million averted infections by 2030.[4] Communities demonstrated resilience through grassroots efforts in testing and adherence.UNAIDS Fact Sheet
Key Takeaways:
- New infections stalled at 1.3 million in 2024, missing ambitious goals.
- Treatment reached 77 percent but children and men trailed.
- Funding gaps demand urgent domestic and international action.
Decades of progress hang in the balance, yet innovations and commitments offer hope for ending AIDS as a public health threat. What do you think world leaders should prioritize next? Tell us in the comments.
